INVO Fertility price to sales ratio IVF

Market value divided by revenue over the last twelve months, since 2017.

Today, Oct 23, 2026: 0.2×
9-year median: 5.9×
Against its 9-year history: 4th; percentile: 0 is its lowest day, 100 its highest
9-year range: 0.1× to 131×
Peer median: 0.4×

INVO Fertility's price to sales ratio is 0.2× as of Oct 23, 2026.

That is below its 9-year median of 5.9×, lower than on 96% of days in the last 9 years.

Over that time it ranged from 0.1× in May 2026 to 131× in Mar 2018.

The median for 3 healthcare stocks of a similar size is 0.4×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	0.2×	0.1×	0.6×
2025	0.2×	0.1×	1.0×
2024	0.7×	0.4×	1.6×
2023	1.7×	1.1×	7.4×
2022	1.4×	1.4×	32.4×
2021	29.9×	12.5×	44.9×
2020	12.8×	3.7×	63.4×
2019	9.0×	8.6×	62.0×
2018	51.1×	24.7×	131×
2017	34.8×	34.8×	79.5×

Against its peers

Companies in Healthcare nearest INVO Fertility's size, closest first, today.

Company	Price to sales ratio
IVFINVO Fertility	0.2×
OXBROXBRIDGE RE HOLDINGS	2.8×
EDUCEducational Development	0.4×
GTIMGood Times Restaurants	0.1×
Peer median	0.4×

Where INVO Fertility ranks

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on INVO Fertility

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.